SCHEMBL13611680

SCHEMBL13611680

CN([SiH3])CCN(Cc1cc(-c2ccc3c(c2)CCN3)ccc1F)C(=O)c1ccc(F)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 3/20 0.36
▸ ROCK1 Q13464 1/20 0.36
▸ OPRD1 P41143 1/20 0.36
▸ MCHR1 Q99705 4/20 0.34
▸ KCNH2 Q12809 2/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ HTT P42858 1/20 0.33
▸ PARP1 P09874 1/20 0.33
▸ CYP2C9 P11712 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ CDK4 P11802 1/20 0.32
▸ CCND1 P24385 1/20 0.32
▸ GABRA1 P14867 1/20 0.32
▸ GABRB2 P47870 1/20 0.32
▸ MAPT P10636 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3695118 0.93 OPRD1 (0.39) ACHEROCK1OPRD1MCHR1KCNH2
SCHEMBL14388564 0.87 ACHE (0.36) ACHEROCK1OPRD1MCHR1KCNH2
SCHEMBL5605723 0.86 ACHE (0.36) ACHEROCK1OPRD1MCHR1KCNH2
SCHEMBL27731815 0.83 ACHE (0.38) ACHEROCK1OPRD1MCHR1KCNH2
SCHEMBL27731820 0.78 ACHE (0.38) ACHEROCK1OPRD1MCHR1KCNH2
SCHEMBL3695341 0.69 NPC1 (0.42) ROCK1MCHR1ALDH1A1KDM4EHPGD
SCHEMBL3695648 0.69 KDM4E (0.47) ROCK1MCHR1ALDH1A1KDM4EHPGD
SCHEMBL3699058 0.67 KDM4E (0.41) ROCK1MCHR1ALDH1A1KDM4EHPGD
SCHEMBL3692381 0.66 CDK4 (0.43) ROCK1KCNH2ALDH1A1KDM4EHPGD
SCHEMBL21042092 0.65 ALDH1A1 (0.50) OPRD1ALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625889-B2 Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists AVENTIS PHARMACEUTICALS INC. (US) 2009-12-01 — — US disclosed
Send feedback